Valeant Pharmaceuticals Intern...

NYSE: VRX
$23.40
-$0.83 (-3.4%)
Closing price July 13, 2018
Here is a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of October.
The top analyst upgrades, downgrades and other research calls from Friday include Bookings Holdings, Dollar General, KLA-Tencor, Micron Technology, Nike and Red Hat.
Valeant Pharmaceuticals shares were down over 5% in premarket trading Monday after the FDA failed to approve the company's lotion intended to treat plaque psoriasis.
The top analyst upgrades, downgrades and other research calls from Wednesday include Alkermes, Cigna, International Paper, Medtronic, Tesla and Western Digital.
The top analyst upgrades, downgrades and other research calls from Tuesday include CBS, Ford, Pivotal Software, Spotify, Symantec and Ulta Beauty.
There is deep value for long-term investors in these specialty pharmaceutical companies, and the ability to buy in to some of the best companies in the industry at rock bottom pricing.
Valeant Pharmaceuticals released its most recent quarterly report and announced a name change before the markets opened on Tuesday.
24/7 Wall St. has put together a preview of Disney, Nvidia, Valeant Pharmaceuticals and of some of the other top companies reporting their latest results in the coming week.
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in May.
The top analyst upgrades, downgrades and other research calls from Friday include Archer Daniels Midland, Boeing, Hess, LogMeIn, NetApp, Sunrun, United Continental, Valeant Pharmaceuticals and XPO...
These six additions to the Deutsche Bank Conviction List are top stocks to buy for the next year for growth accounts looking to add new positions.
Valeant Pharmaceuticals saw its shares make a handy gain on Monday after Deutsche Bank upgraded the stock.
The top analyst upgrades, downgrades and other research calls from Monday include AMAG Pharmaceuticals, Foot Locker, Groupon, H&R Block, McDonald's, Teradata, Under Armour and Valeant...
Valeant Pharmaceuticals shares tumbled after it reported its most recent quarterly results early Wednesday.
24/7 Wall St. has put together a preview of Square, Valeant Pharmaceuticals and some of the other top companies reporting their latest results in the coming week.